The choppy/consolidating (or perhaps worse) market conditions sometimes give the impression that growth plays do not exist, but that is not the case, and one growth company worth reviewing is Intuitive Surgical. (Note: Intuitive Surgical is only for investors who can tolerate high risk.)
Intuitive Surgical (NASDAQ: ISRG) has developed the da Vinci Surgical System of software, hardware and optics that allows doctors to perform robotically-aided surgery from a remote console.
Analysts believe 2008 revenue will move substantially higher on instrument and accessories sales, pricing power and high-definition system upgrades. Yes, high definition is coming to surgery, too.
Longer term, analysts see Intuitive's technology broadening to new surgical procedures. Margins remain massive and are likely to approach 75% in 2008. The Reuters F2008/F2009 EPS consensus estimates for ISRG are $5.05/$6.81.
Intuitive Surgical (NASDAQ: ISRG) has developed the da Vinci Surgical System of software, hardware and optics that allows doctors to perform robotically-aided surgery from a remote console.
Analysts believe 2008 revenue will move substantially higher on instrument and accessories sales, pricing power and high-definition system upgrades. Yes, high definition is coming to surgery, too.
Longer term, analysts see Intuitive's technology broadening to new surgical procedures. Margins remain massive and are likely to approach 75% in 2008. The Reuters F2008/F2009 EPS consensus estimates for ISRG are $5.05/$6.81.
Struggling Playboy outsources business ops
J. Crew earnings preview: A strong Q3 all buttoned up?
Twitter to make acquisitions, generate revenue in 2010
